Thermo Fisher Scientific (TMO) Acquisitions (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Acquisitions for 18 consecutive years, with $8.9 billion the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Acquisitions changed N/A year-over-year to $8.9 billion; the trailing twelve-month figure through Jun 2026 stood at $12.9 billion (up 312.16% YoY), and the FY2025 full-year result was $4.0 billion, up 28.9% from the prior year.
• Acquisitions climbed to $8.9 billion in Q1 2026 per TMO's latest filing, from $4.0 billion in the prior quarter.
• Across five years, Acquisitions topped out at $8.9 billion in Q1 2026 and bottomed at -$1.0 million in Q4 2022.
• Historically, Acquisitions has averaged $2.5 billion across 5 years, with a median of $1.8 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Acquisitions plunged 101.06% in 2022, then surged 91000.0% in 2023.
• Over 5 years, Acquisitions stood at -$1.0 million in 2022, then soared by 91000.0% to $909.0 million in 2023, then jumped by 244.55% to $3.1 billion in 2024, then climbed by 28.9% to $4.0 billion in 2025, then soared by 119.77% to $8.9 billion in 2026.
• According to Business Quant data, Acquisitions over the past three periods registered $8.9 billion, $4.0 billion, and $3.1 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.